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ABSTRACT
Objective: melatonin has been demonstrated to have active
antioxidant properties in different tissues during experimental
cholestasis. The aim of this research was to study myocardial ox-
idative stress on obstructive jaundice, and to analyze the effect of
melatonin on myocardial oxidative lesions.
Material and methods: we achieved cholestasis by ligature
and sectioning of the main bile duct. Melatonin was administered
intraperitoneally (500 µg/kg/day). We measured malondialdehyde
(MDA), reduced glutathione (GSH), catalase (CAT), superoxide
dismutase (SOD) and glutathione peroxydase (GPx) antioxidant
enzyme levels in the heart tissue.
Results: obstructive cholestasis increased MDA and decreased
GSH as well as all antioxidant enzymes. Melatonin administration
significantly decreased MDA values, and increased GSH and an-
tioxidant enzymes on the icteric animal myocardium.
Conclusions: melatonin treatment prevents oxidative stress
in the cardiac tissue as induced by experimental cholestasis.
Key words: Antioxidants. Cholestasis. Cardiac dysfunction.
Melatonin. Oxidative stress.
INTRODUCTION
Biliary obstruction has an important effect both on the
liver and extrahepatic organs (1). Obstructive jaundice
(OJ) increases oxidative stress, characterized by a rise of
systemic malondialdehyde (MDA) and a decrease in cel-
lular antioxidant defenses, such as reduced glutathione
(GSH) and antioxidant enzymes (2). The rise of different
parameters of oxidative stress during experimental OJ
has been shown in serum (2), hepatic (2) and renal (3)
parenchyma, and on the central nervous system, specifi-
cally on the hypothalamus, bulb and cerebral cortex (4).
Oxidative stress has been related to serious complications
in liver (5-7) and renal dysfunction (3). OJ has been
shown to induce hypotension and fluid depletion (8).
Moreover, it has also been suggested that biliary obstruc-
tion causes depression mainly in myocardial contractility
of the left ventricle (9). Melatonin is a hormone with
great antioxidant capacity (10). Its beneficial effects
against oxidative stress have also been demonstrated in
liver cirrhosis (11) and acute pancreatitis (12). The aims
of our study were firstly to measure oxidative stress in
the myocardium tissue after biliary obstruction, and sec-
ondly to demonstrate the antioxidant properties of mela-
tonin in myocardial tissue during obstructive cholestasis.
METHODS
Animals
Male Wistar rats (250-330 g) were subjected to con-
trolled conditions of temperature (about 22-24 ºC) and il-
lumination (12-h light: 12-h dark cycle), and were pro-
vided with food (Purina®, Barcelona, Spain) and water ad
libitum. Animals were treated according to institutional
guidelines, and the study was approved by the Research
Committee of the Reina Sofía University Hospital.
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Experimental design
Animals (n = 21, 7 in each group) were distributed in
each of the following groups: sham operated (SO), OJ,
and OJ plus melatonin (OJ + MEL). All the surgical
procedures were done in animals anesthetized with ket-
amine (60 mg/kg i.p.) and midazolam (4 mg/kg i.p.).
Cephazoline (17 mg/kg i.m.) was used as antibiotic pro-
phylaxis. SO animals were submitted to laparotomy and
abdominal closure without bile duct intervention. The
procedure for OJ was started by a midline ventral inci-
sion with exposure of the extra-hepatic bile duct. A dou-
ble ligature with silk suture was done and the bile duct
was sectioned. A two-layer running suture was used for
abdominal closure with polyglycolic acid and silk.
Melatonin (500 µg/kg/day i.p.; Sigma-Aldrich, St
Louis, MO) was diluted in 5% ethanol in 0.9% NaCl.
The administration of the solvent did not change the pa-
rameters (data not shown). Melatonin was injected daily
at 10 h starting the day before the bile duct ligature was
made, and until the day preceding the sacrifice. The ani-
mals were sacrificed under anesthesia 7 days after OJ.
Blood was collected from the abdominal aorta and
serum was frozen at -80 ºC until the measurement of al-
kaline phosphatase (AP) and total bilirubin. The heart
was dissected, aliquot and immediately frozen at -80 ºC
until the measurements could be taken. Tissue was ho-
mogenized in ice-cold phosphate-EDTA buffer (10 mM
phosphate buffer [pH 7.2], containing 1 mM EDTA and
1 mM BHA diluted in 0.15% ethanol) using a glass-
glass Potter-Elvehjem homogenizer.
Biochemical assays
Total bilirubin and AP were measured in serum us-
ing an Axon analyzer (Bayer Diagnostics, Tarrytown,
NY). MDA was determined in tissue according to the
procedure described in the assay (LPO-586, Bioxytec,
Portland, OR). A GSH-400 assay commercial kit
(Bioxytec, Portland, OR) was used for measuring GSH
in tissue. Catalase (CAT) and superoxide dismutase
(SOD) activities were measured according to Aebi (13)
and Sun (14), respectively. Glutathione peroxidase
(GPx) was measured according to Flohe and Gunzler
(15).
Statistical analysis
The results are expressed as means with their corre-
sponding standard errors. Homogeneity of variance was
assessed with Levene’s test. Comparisons were made us-
ing the two-tailed, unpaired Student’s t test and ANOVA
test. Statistical significance was set at p < 0.05.
RESULTS
The biliary obstruction model caused acute cholestasis
in OJ animals, characterized by a significant increase in
both total bilirubin and AP in comparison with SO ani-
mals (Table I). Regarding this effect, animals which un-
derwent bile-duct obstruction had a significant increase
in the MDA oxidative stress marker in the myocardium
(Fig. 1). Moreover, a positive correlation between serum
AP and MDA concentration has been shown in myocar-
dial tissue (Fig. 2). In addition to increased lipoperoxides,
the concentration of antioxidant defenses was drastically
reduced in the myocardium of OJ animals. In this respect,
OJ induced a significant decrease in GSH (Fig. 3) and in
antioxidant enzymes SOD, CAT and GPx (Fig.4).
On the other hand, melatonin administration to icteric
animals determined a significant restoration of oxidative
stress markers in the myocardium. Melatonin decreased
MDA concentration and increased GSH (Figs. 1 and 3),
and likewise recovered the activity of all the enzymatic
antioxidants studied (Fig. 4).
DISCUSSION
The study of the involvement of oxidative stress during
OJ has identified several potential agents that exert a ben-
eficial effect against tissue injury induced by biliary ob-
struction. Oxidative stress by OJ is characterized by a rise
of lipoperoxides and a reduction of cellular antioxidant
status. A rise in MDA in the liver parenchyma and serum
has been observed in animals with biliary obstruction (2).
The reduction in blood antioxidant concentration may
have a relevant repercussion on different tissues during
OJ. In addition, free radicals may originate in extrahepatic
organs or in organs not related to the biliary tree during
OJ. We have proven that there is increased oxidative
stress in the kidney (3) and central nervous system (4) that
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Table I. Cholestatic markers in the serum of rats with obstructive jaundice
SO OJ p OJ-MEL p*
Total bilirubin (mg/dL) 0.12 ± 0.030 9.5 ± 0.80 < 0.0001 7.7 ± 0.10 < 0.05
AP (U/L) 86.5 ± 21.79 378 ± 26.0 < 0.0001 354 ± 13.2 n.s.
*In relation to the OJ group. SO: Sham operated; OJ: Obstructive jaundice group; OJ-MEL: Animals treated with melatonin after biliary obstruction.
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may explain various complications during cholestasis. On
the lines of the impact of biliary obstruction on extrahep-
atic organs, this study proves for the first time an increase
in MDA and a decrease in GSH and antioxidant enzymes
in the myocardium from OJ rats. It has been recognized
that bile-duct obstruction has a detrimental effect on car-
diovascular physiology (16). A more recent study has
shown a reverse correlation between the left ventricle sys-
tolic work and bilirubin in obstructive jaundice patients,
suggesting that bile-duct obstruction has a depressor ef-
fect on myocardial contractility, mainly in the left ventri-
cle (8). This fact could help explain the pathophysiology
of shock in patients suffering from severe cholangitis, and
could be important for icteric patients with previous heart
disease. In addition to that, in the above-mentioned study,
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Fig. 1. Reduction of malondialdehyde (MDA) content by melatonin in
cardiac tissue from obstructed animals. Obstructive jaundice (OJ) was
induced in control animals (SO) by bile duct ligation. The OJ-MEL group
was submitted to OJ and received melatonin (500 µg/kg) daily until
their sacrifice 7 days after the surgical intervention. MDA was determi-
ned in myocardial tissue following the procedure described in “Ani-
mals” (Methods). Statistical significance was set at p ≤ 0.0001; ªsignifi-
cantly different from the SO group.
Fig. 3. Recovery of reduced glutathione (GSH) content by melatonin in
the myocardium tissue from obstructed animals. Obstructive jaundice
(OJ) was induced in control animals (SO) by bile duct ligation. The OJ-
treated animals (OJ-MEL) received melatonin (500 µg/kg) daily until
their sacrifice 7 days after the surgical intervention. GSH was determi-
ned in myocardium tissue following the procedure described in “Ani-
mals” (Methods). Statistical significance was set at p ≤ 0.0001; ªsignifi-
cantly different from the SO group.
Fig. 4. Recovery of antioxidant status by melatonin in cardiac tissue
from obstructed animals. Obstructive jaundice (OJ) was induced in con-
trol animals (SO) by bile duct ligation. The OJ-MEL group was submit-
ted to OJ and received melatonin (500 µg/kg) daily until their sacrifice
7 days after the surgical intervention. Superoxide dismutase (SOD), ca-
talase (CAT) and glutathione peroxidase (GSH-Px) were measured in
myocardium tissue following the procedure described in “Animals”
(Methods). Statistical significance was set at p ≤ 0.0001; ªsignificantly
different from the SO group.
Fig. 2. Correlation analysis between alkaline phosphatase (AP) and ma-
londialdehyde (MDA) in animals submitted to bile duct ligation (OJ).
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biliary drainage allowed a normalization of hemodynamic
parameters (8). The existence of a higher redox state in
patients suffering from cardiac insufficiency has been
proven, this being correlated with functional parameters;
so there is a reverse connection between MDA figures and
ventricular ejection fraction (17). Although we have not
evaluated hemodynamic dysfunction in our study, we
have clearly demonstrated an increase in myocardial ox-
idative stress, which could be involved in myocardial dys-
function in OJ rats. Moreover, a positive correlation be-
tween AP and MDA in the myocardium has been proven,
which suggests an increase in myocardium oxidative
damage when a worsening of cholestasis occurs. Al-
though surgical procedures for cholestasis, such as biliary
drainage, are suitable for the treatment of OJ, we have
successfully tested antioxidant therapies to reduce the ox-
idative damage associated with OJ. Melatonin has demon-
strated hepatoprotective properties on experimental
cholestasis (5) and drastically improves oxidative stress
parameters in the renal parenchyma (3). The discovery of
melatonin as a direct scavenger of free radicals and as an
indirect antioxidant stimulating antioxidant enzymes has
raised interest in its potential cardioprotective properties
(18). Our study suggests that the cardioprotection of mela-
tonin was related to a reduction of MDA and a restoration
of the antioxidant status in the myocardium. Melatonin
had beneficial effects on other myocardial dysfunctions
such as ischemia reperfusion (19), reducing areas with
heart congestion (20). On the basis of experimental re-
sults, we suggest that melatonin could have a protective
effect on myocardial dysfunction generated in OJ that
may be relevant in order to decrease the systemic compli-
cations of these patients. Melatonin has demonstrated an-
tihypertensive properties (21) that would have a beneficial
impact on ventricular function. In addition, melatonin has
pharmacological advantages such as oral administration,
excellent tissue distribution both in fat-soluble and water-
soluble environments, and its capacity to be highly concen-
trated in every section of the cell, especially in mitochon-
dria, which is very important for myocardial cells (18).
In conclusion, myocardial biochemical oxidative dys-
function induced by biliary obstruction may be counter-
acted upon by melatonin. However, we should carry out
new clinical trials to prove the benefits of antioxidant
therapy with melatonin, and to help decrease mortality
rates among patients with obstructive cholestasis.
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